Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$14,738,640
+$702,897 QoQ
Shares Held
58,033
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#893
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GHP Investment Advisors, Inc. holds $46,475,498 across 14 Drug Manufacturers - General names. JNJ ranks #2 (31.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
118,345 | $15,207,332 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
58,033 | $14,738,640 | |
| 3 | AMGN |
Amgen Inc
|
28,143 | $10,191,142 | |
| 4 | LLY |
ELI LILLY & Co
|
1,816 | $2,178,165 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,971 | $1,638,755 | |
| 6 | ABBV |
AbbVie Inc.
|
5,799 | $1,459,260 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,952 | $342,954 | |
| 8 | NVO |
Novo Nordisk A S
|
4,826 | $231,358 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,738,640 | 58,033 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $14,035,743 | 57,420 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $11,923,424 | 57,615 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $10,417,451 | 56,183 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $8,520,242 | 55,779 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $9,125,511 | 55,026 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,911,292 | 54,704 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,671,992 | 53,511 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $7,732,302 | 52,903 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $8,192,027 | 51,786 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $7,852,987 | 50,102 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $7,870,670 | 50,534 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $8,141,763 | 49,189 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,267,330 | 46,886 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $8,167,059 | 46,233 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $7,292,553 | 44,641 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,777,245 | 43,813 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $7,345,474 | 41,446 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $6,922,347 | 40,465 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,526,861 | 40,414 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,640,669 | 40,310 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,538,336 | 39,783 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,047,011 | 38,423 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,622,750 | 37,767 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,290,641 | 37,621 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,936,388 | 37,645 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||